Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Mar 24, 2022 11:26pm
Vaccine
https://www.bloomberg.com/press-releases/2022-03-24/race-to-develop-universal-variant-proof-covid-vaccine-involves-several-players
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Mar 23, 2022 10:34am
Level 2 bid ask to .19
Ask 0.19 34,832 2 0.18 1,000 1 0.16 95,000 5 0.155 2,000 2 0.145
...more
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development
posted May 02, 2024 9:00am by
Saturn Oil & Gas Inc.
-
|
Saturn has followed up its success in previous years drilling in Southeast Saskatchewan to enhance its IP30 initial production rates and overall return on invested capital. Saturn has recently finished drilling one gross (1.0 net) Open Hole Multi-Lateral ("OHML") well in the Viewfield area of Southeast Saskatchewan with eight horizontal legs of up to two miles each ...read more
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Mar 22, 2022 10:48am
Asks to .155
0.155 9,000 3 0.15 500 1 0.145 8,500 2 0.14 20,000 1
(2)
•••
marpip3
X
View Profile
View Bullboard History
Comment by
marpip3
on Mar 22, 2022 10:30am
RE:Demand
Demand for Greater Public Protection Calls for Creation of Next-Generation, Pan-COVID Vaccines Biotech Insider – The US White House
...more
(2)
•••
marpip3
X
View Profile
View Bullboard History
Post by
marpip3
on Mar 22, 2022 10:13am
The news yesterday wasa deal with Millipore
Millipore is a subsidiary of Merck KGaA (Deutsche Bourse: MRCG), one of the largest pharmaceutical companies in the world, with a market capitalization of US$81 billion. They seem to have
...more
(2805)
•••
frankman
X
View Profile
View Bullboard History
Comment by
frankman
on Mar 22, 2022 9:35am
RE:Frank, you disappoint me....
Well Magnum work on different product advances continue in spite of world upheaval as you see in the last nr. Still a low share float of 72 mil and zero insider selling with CEO being a majority
...more
(2805)
•••
frankman
X
View Profile
View Bullboard History
Comment by
frankman
on Mar 22, 2022 9:13am
RE:That is a new PR firm on nr CEO e-mailed me just now
With the upcoming news of the clean room completion the new PR firm will switch to more digital images and a focus on Canadian retail.
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Mar 21, 2022 8:23pm
Demand
https://www.baystreet.ca/stockstowatch/12547/Demand-for-Greater-Public-Protection-Calls-for-Creation-of-Next-Generation-Pan-COVID-Vaccines
(16)
•••
Magnum2
X
View Profile
View Bullboard History
Post by
Magnum2
on Mar 21, 2022 5:45pm
Frank, you disappoint me....
still pumping this dead DAWG, buckle up /sell, either way, wait for the rollback, these guys have done it before! CEO is bluffing, it ain't working.... DYODD
(2805)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Mar 21, 2022 1:39pm
That is a new PR firm on nr CEO e-mailed me just now
We are going to catch up and chat later. Government & Media Relations JB&A, Inc. Davin Shinedling davin@jennibyrne.com 1 (647) 991-6447
(4)
•••
johnfever21
X
View Profile
View Bullboard History
Post by
johnfever21
on Mar 21, 2022 9:20am
There are still billions of non vaccinated globally with
others having fading immunity. Ba2 variant starting to dominate. A continuous breeding ground for covid/sars type viruses. Big pharma has not cured the world. Lots of room for other players
...more
(4)
•••
johnfever21
X
View Profile
View Bullboard History
Post by
johnfever21
on Mar 21, 2022 8:56am
Biov to develop omni variant booster
Biovaxys intends to develop BVX-1021 as a stand-alone booster targeting anyone who has been immunized with a World Health Organization recognized COVID-19 vaccine or convalesced from a COVID-19
...more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Mar 18, 2022 8:51pm
Interview
https://m.youtube.com/watch?v=1Ygsi_2KLIc
(10)
•••
mba123ccu
X
View Profile
View Bullboard History
Comment by
mba123ccu
on Mar 17, 2022 9:06am
RE:News BioVaxys Announces Bioproduction of BVX-1021 for its Pa
This sounds good, although Covid-19 is arguably on the decline - this vacine that BIOV is collaborating with Ohio State U. has the potential to test at least 10 subvariants and some other viruses.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up